Henderson Jane sold APGE
November 14, 2025 · Form 4 insider transaction
Henderson Jane sold 2,000 shares of Apogee Therapeutics, Inc. at $65.00 per share, a transaction worth $130.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
2,000
Price
$65.00
Total value
$130.0K
InsiderHenderson Jane
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateNovember 14, 2025
Filing dateNovember 14, 2025
Shares owned after197,871
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on September 27, 2024.